Meta AnalysisID 6644
口服中成药联合ARB对糖尿病肾病患者TNF-α、IL-6和hs-CRP影响的网状Meta分析
CRD42018110989
In the commonly used Oral Chinese Patent Medicines combined with Angiotensin Receptor Blocker (ARB) dosage regimens, which kind of Oral Chinese Patent Medicine combined with ABR dosage regimen will be the best way to red
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Formula: 1Meta-analysis: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final meta_analysis record.
- Meta Analysis Id
- 6644
- Evidence Id
- 15202
- Core Evidence Id
- 15202
- Source Meta Analysis Id
- 6627
- Herb2 Meta Analysis Id
- HBMA006627
- Crd Id
- CRD42018110989
- Title
- Effects of oral Chinese patent medicine combined with ARB on TNF- α, IL-6 and hs-CPR in diabetic nephropathy patientsa network meta-analysis
- Review Question
- In the commonly used Oral Chinese Patent Medicines combined with Angiotensin Receptor Blocker (ARB) dosage regimens, which kind of Oral Chinese Patent Medicine combined with ABR dosage regimen will be the best way to reduce the levels of inflammatory factors (TNF- α, IL-6 and hs-CPR) in patients with Diabetic Nephropathy?
- Study Type Included
- Randomized controlled trial.
- Condition Being Studied
- Diabetic Nephropathy with abnormal levels of inflammatory factors (TNF- α, IL-6 and CPR).
- Participant
- The participants meet the diagnostic criteria for diabetic nephropathy established by the American Diabetes Association.
- Animal
- Human Disease Modelled
- Intervention
- The experimental group adopted Oral Chinese Patent Medicine combined with ARB：including Tianqi Jiangtang capsule，ShenyanShu，Bailing capsule，Paecilomyces hepiall chen，Xuesaitong soft capsule，Luhuang Shenhua capsule，Qiming granule，Huangkui capsule，Naoxintong capsule，Nephritis rehabilitation tablet or Tangshenkang combined with ARB.
- Comparator Control
- The control group adopted Oral Chinese Patent Medicine combined with ARB：including Tianqi Jiangtang capsule，ShenyanShu，Bailing capsule，Paecilomyces hepiall chen，Xuesaitong soft capsule，Luhuang Shenhua capsule，Qiming granule，Huangkui capsule，Naoxintong capsule，Nephritis rehabilitation tablet or Tangshenkang combined with ARB.
- Main Outcome
- The levels of TNF- α, IL-6 and CPR. Measures of effect From baseline to the last available follow-up.
- Outcome Measure
- Additional Outcome
- None. Measures of effect Not applicable.
- Study Method
- Narrative synthesis, Network meta-analysis, Systematic review
- Keyword
- Angiotensin-Converting Enzyme Inhibitors; Asian Continental Ancestry Group; Cardiopulmonary Resuscitation; Diabetic Nephropathies; Humans; Interleukin-6; Medicine, East Asian Traditional; Network Meta-Analysis; Nonprescription Drugs; Oral Medicine
- Contact
- Wenmin Zhu [email protected]
- Organisational Affiliation
- College of Health Science & Nursing of Wuhan Polytechnic University
- Funding Source
- Funding sources:Wuhan Polytechnic University Identification numbers:124200004416255673
- Other Selection Criteria
- Final Publication
- Same Topic Review
- Published Protocol
- Review Type
- Language
- English
- Country
- China
- Review Stage
- Review Completed not published
- First Submission Date
- 2018-10-24
- Registration Date
- 2018-11-14
- Anticipated Start Date
- 2018-10-24
- Anticipated Completion Date
- 2019-02-28
- Title Cn
- 口服中成药联合ARB对糖尿病肾病患者TNF-α、IL-6和hs-CRP影响的网状Meta分析
- Title En
- Effects of oral Chinese patent medicine combined with ARB on TNF- α, IL-6 and hs-CPR in diabetic nephropathy patientsa network meta-analysis
- Bilingual Status
- complete